Method of treating an anxiety disorder
US8592420B2 · kind B2 · utility
0Cited by
3References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2012 |
| Grant date | Nov 26, 2013 |
| Priority date | — |
| Expiry date | Apr 16, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anxiety disorders, such as panic disorder, agoraphobia, obsessive-compulsive disorder, social phobia, post-traumatic stress disorder, generalized anxiety disorder, specific phobia, or the like, are treated by administering an effective amount of at least one adenosine A2A receptor antagonist to a patient in need thereof, optionally in combination with an anxiolytic(s) other than the adenosine A2A receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.